016580 — Whanin Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapTurnaround

Annual cashflow statement for Whanin Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	26,459	23,734	29,774	23,381	13,595
Depreciation
Amortisation
Non-Cash Items	7,713	7,443	4,480	7,268	6,306
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-2,578	-18,700	-17,244	-17,937	-20,235
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	35,318	16,851	23,197	20,693	9,044
Capital Expenditures	-4,762	-67,759	-31,489	-29,381	-6,182
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	2,640	28,817	22,057	11,286	10,930
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-2,122	-38,942	-9,432	-18,095	4,747
Financing Cash Flow Items	—	—	-171	-4.95	308
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-5,194	-5,130	-5,166	-5,051	6,584
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	27,982	-27,280	8,591	-2,219	20,433